Sicen Wang Selected Research

Sicen Wang Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 01/2010
4	Glioma (Gliomas) 10/2022 - 01/2022
3	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 01/2021
3	Dysbiosis 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 07/2014
3	Colitis 01/2022 - 01/2021
2	Insulin Resistance 02/2023 - 01/2021
2	Circulating Neoplastic Cells 02/2023 - 01/2023
2	Neuroinflammatory Diseases 04/2022 - 01/2021
2	Hyperplasia 12/2021 - 12/2020
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Substance-Related Disorders (Drug Abuse) 01/2024
1	Atrial Fibrillation 01/2023
1	Starvation 03/2022
1	Cognitive Dysfunction 03/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	COVID-19 10/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2021
1	Hypotension (Low Blood Pressure) 02/2021
1	Headache (Headaches) 02/2021
1	Adenocarcinoma of Lung 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2021
3	Temozolomide (Temodar)FDA LinkGeneric 12/2023 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022 - 05/2014
3	Ribosomal DNA (rDNA)IBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 08/2010
2	Oxygen (Dioxygen)IBA 10/2023 - 03/2022
2	Dextran SulfateIBA 01/2021 - 01/2021
2	AlkaloidsIBA 01/2021 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 07/2014
2	schizandrin AIBA 12/2020 - 01/2019
2	AntioxidantsIBA 01/2018 - 12/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015 - 01/2013
2	sinapineIBA 05/2014 - 01/2013
1	Docetaxel (Taxotere)FDA Link 04/2024
1	CarbonIBA 04/2024
1	Analgesics (Analgesic Drugs)IBA 01/2024
1	Mitochondrial DNA (mtDNA)IBA 12/2023
1	honatisineIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	DiterpenesIBA 12/2023
1	perfluorotributylamine (FC 43)IBA 10/2023
1	Photosensitizing Agents (Photosensitizers)IBA 10/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023
1	Liposomes (Liposome)IBA 10/2023
1	magnololIBA 09/2023
1	honokiolIBA 09/2023
1	Insulin (Novolin)FDA Link 02/2023
1	graphene oxideIBA 02/2023
1	gypenoside LXXVIBA 02/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	SaltsIBA 01/2023
1	cucurbitaneIBA 10/2022
1	TriterpenesIBA 10/2022
1	Adenosine (Adenocard)FDA LinkGeneric 09/2022
1	AMP-Activated Protein KinasesIBA 09/2022
1	MicroRNAs (MicroRNA)IBA 09/2022
1	Glucose OxidaseIBA 03/2022
1	arginyl-glycyl-aspartic acidIBA 03/2022
1	antineoplaston A10 (A 10)IBA 03/2022
1	Metal-Organic FrameworksIBA 03/2022
1	LigandsIBA 03/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 03/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2022
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	PrebioticsIBA 01/2022
1	SesquiterpenesIBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2022
1	MelatoninIBA 01/2022
1	neferineIBA 12/2021
1	SolutionsIBA 10/2021
1	VaccinesIBA 10/2021
1	hydroxysafflor yellow AIBA 08/2021
1	AnticoagulantsIBA 08/2021
1	Thrombin FDA Link 08/2021
1	StreptavidinIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	liensinineIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	BerberineIBA 01/2021
1	15-deoxyprostaglandin J2IBA 01/2021
1	dihydromyricetinIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020
1	EnzymesIBA 11/2020
1	Glutathione (Reduced Glutathione)IBA 11/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2020
1	quinone (benzoquinone)IBA 11/2020

Therapy/Procedure

11	Therapeutics 04/2024 - 03/2012
5	Drug Therapy (Chemotherapy) 03/2022 - 01/2019
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2021 - 03/2012
1	Photochemotherapy (Photodynamic Therapy) 10/2023
1	Bioreactors (Bioreactor) 03/2022
1	Intranasal Administration 01/2021